APERAM financials
APERAM
Country: LU Reporting currency: EUR Latest annual report: 2021-12-31
LEI:
5493001136GE6L4R7M63 ISIN: LU0569974404 Financial statements
(EUR, as reported — unscaled; 101 line items across 2 annual periods)
| Line item | 2021 | 2020 |
|---|---|---|
| Income statement | ||
| Cost of sales | €3.87B | €3.26B |
| Gross profit | €1.23B | €368.0M |
| Operating profit (EBIT) | €1.04B | €199.0M |
| Profit before tax | €1.04B | €238.0M |
| Income tax expense | €74.0M | €63.0M |
| Profit for the year | €969.0M | €175.0M |
| — attributable to owners | €968.0M | €175.0M |
| — attributable to NCI | €1.0M | €0 |
| Total comprehensive income | €988.0M | -€77.0M |
| Per share | ||
| Basic EPS | €12.21 | €2.19 |
| Diluted EPS | €12.16 | €2.19 |
| Free cash flow / share | €4.99 | €2.43 |
| Cash flow statement | ||
| Net cash from operating activities | €550.0M | €303.0M |
| Income taxes paid | €56.0M | €4.0M |
| Net cash from investing activities | -€183.0M | -€108.0M |
| Purchase of PP&E (capex) | €152.0M | €109.0M |
| Net cash from financing activities | -€197.0M | -€185.0M |
| Dividends paid | €140.0M | €139.0M |
| Proceeds from borrowings | €75.0M | €0 |
| Net change in cash | €166.0M | -€17.0M |
| Balance sheet | ||
| Total assets | €5.91B | €3.97B |
| Non-current assets | €2.40B | €2.13B |
| Property, plant & equipment | €1.70B | €1.49B |
| Intangible assets & goodwill | €439.0M | €429.0M |
| Current assets | €3.51B | €1.84B |
| Cash & equivalents | €524.0M | €358.0M |
| Total equity | €2.95B | €2.20B |
| — attributable to owners | €2.94B | €2.20B |
| Non-controlling interests | €8.0M | €4.0M |
| Non-current liabilities | €1.10B | €681.0M |
| Current liabilities | €1.85B | €1.08B |
| Short-term borrowings | €271.0M | €53.0M |
| Trade & other payables | €1.20B | €714.0M |
| Deferred tax liabilities | €132.0M | €117.0M |
| Derived metrics | ||
| Free cash flow | €398.0M | €194.0M |
| Return on equity | 32.8% | 7.9% |
| Cash conversion ratio | 0.57× | 1.73× |
| Capex coverage | 3.62× | 2.78× |
| Other reported items | ||
| Accumulated Other Comprehensive Income | -€718.0M | -€737.0M |
| Additional Paidin Capital | €1.10B | €1.10B |
| Adjustments For Decrease Increase In Inventories | -€748.0M | €57.0M |
| Adjustments For Decrease Increase In Trade Account Receivable | -€132.0M | -€18.0M |
| Adjustments For Decrease Increase In Trade and Other Receivables | €59.0M | -€77.0M |
| Adjustments For Depreciation and Amortisation Expense | €144.0M | €144.0M |
| Adjustments For Gains Losses On Change In Fair Value of Derivatives | €2.0M | -€4.0M |
| Adjustments For Income Tax Expense | €74.0M | €63.0M |
| Adjustments For Increase Decrease In Employee Benefit Liabilities | -€8.0M | €16.0M |
| Adjustments For Increase Decrease In Trade Account Payable | €395.0M | -€62.0M |
| Adjustments For Unrealised Foreign Exchange Losses Gains | -€36.0M | -€7.0M |
| Cash and Cash Equivalents In Subsidiary Or Businesses Acquired Or Disposed2013 | €6.0M | €0 |
| Cash Flows From Used In Increase Decrease In Current Borrowings | -€18.0M | -€37.0M |
| Cash Flows Used In Obtaining Control of Subsidiaries Or Other Businesses Classified As Investing Activities | €31.0M | €0 |
| Comprehensive Income Attributable To Noncontrolling Interests | €1.0M | €0 |
| Comprehensive Income Attributable To Owners of Parent | €987.0M | -€77.0M |
| Current Accrued Expenses and Other Current Liabilities | €321.0M | €240.0M |
| Current Prepaid Expenses | €89.0M | €149.0M |
| Current Provisions | €27.0M | €39.0M |
| Current Tax Assets Current | €5.0M | €2.0M |
| Current Tax Liabilities Current | €34.0M | €38.0M |
| Deferred Tax Assets | €135.0M | €94.0M |
| Depreciation Amortisation and Impairment Loss Reversal of Impairment Loss Recognised In Profit Or Loss | €144.0M | €144.0M |
| Effect of Exchange Rate Changes On Cash and Cash Equivalents | -€4.0M | -€27.0M |
| Equity and Liabilities | €5.91B | €3.97B |
| Gain Recognised In Bargain Purchase Transaction | €119.0M | €0 |
| Gains Losses On Cash Flow Hedges Net of Tax | €16.0M | -€3.0M |
| Income Tax Relating To Cash Flow Hedges of Other Comprehensive Income | €6.0M | -€2.0M |
| Income Tax Relating To Exchange Differences On Translation of Other Comprehensive Income | €0 | €0 |
| Income Tax Relating To Remeasurements of Defined Benefit Plans of Other Comprehensive Income | €6.0M | -€1.0M |
| Increase Decrease Through Other Contributions By Owners | €4.0M | — |
| Increase Decrease Through Sharebased Payment Transactions | €2.0M | €5.0M |
| Interest Paid Classified As Operating Activities | €4.0M | €7.0M |
| Interest Received Classified As Operating Activities | €4.0M | €7.0M |
| Inventories Total | €2.33B | €1.10B |
| Issued Capital | €419.0M | €419.0M |
| Liabilities | €2.96B | €1.76B |
| Noncurrent Biological Assets | €31.0M | €30.0M |
| Noncurrent Investments Other Than Investments Accounted For Using Equity Method | €4.0M | €2.0M |
| Noncurrent Portion of Noncurrent Secured Bank Loans Received | €719.0M | €372.0M |
| Noncurrent Provisions | €60.0M | €37.0M |
| Number of Shares Authorised | 88.1M | 88.1M |
| Number of Shares Issued | 80.0M | 80.0M |
| Number of Shares Outstanding | 77.9M | 79.9M |
| Other Assets | €101.0M | €83.0M |
| Other Comprehensive Income | €19.0M | -€252.0M |
| Other Comprehensive Income Net of Tax Cash Flow Hedges | -€1.0M | €5.0M |
| Other Comprehensive Income Net of Tax Exchange Differences On Translation | €5.0M | -€255.0M |
| Other Comprehensive Income Net of Tax Gains Losses On Remeasurements of Defined Benefit Plans | €15.0M | -€2.0M |
| Other Inflows Outflows of Cash Classified As Financing Activities | -€9.0M | -€9.0M |
| Other Inflows Outflows of Cash Classified As Investing Activities | €0 | €1.0M |
| Other Noncurrent Financial Liabilities | €8.0M | €7.0M |
| Payments To Acquire Or Redeem Entitys Shares | €105.0M | €0 |
| Provisions For Employee Benefits | €186.0M | €148.0M |
| Purchase of Treasury Shares | €105.0M | — |
| Reclassification Adjustments On Cash Flow Hedges Net of Tax | €17.0M | -€8.0M |
| Retained Earnings | €2.25B | €1.42B |
| Revenue From Sale of Goods | €5.10B | €3.62B |
| Revenue From Sale of Goods Related Party Transactions | €73.0M | €49.0M |
| Selling General and Administrative Expense | €191.0M | €169.0M |
| Trade Receivables | €556.0M | €229.0M |
| Treasury Shares | €106.0M | €4.0M |
| Writedowns Reversals of Inventories | €10.0M | €12.0M |
Methodology
Every line item above is a fact tagged in APERAM's annual report
filed in the European Single Electronic Format (ESEF) under the IFRS
taxonomy (ifrs-full) — the income statement, balance sheet
and cash-flow statement as the filer reported them. Values are shown
as-is, in the reporting currency (EUR), without
rescaling; the row labels map to the underlying concept name (e.g.
Revenue → ifrs-full:Revenue, Operating profit →
ifrs-full:ProfitLossFromOperatingActivities, Diluted EPS →
ifrs-full:DilutedEarningsLossPerShare), and any concept
without a curated label is shown under “Other reported items” with its
de-camel-cased tag name. Only consolidated, default-member facts are
shown (segment / dimensional breakdowns are excluded).
“Derived metrics” (free cash flow, margins, ROE, …) are computed from those facts by the same model the U.S. financials pages use — not tagged by the filer.
Source: machine-readable OIM xBRL-JSON aggregated by filings.xbrl.org (XBRL International). Entity identity is resolved by LEI via the public-domain GLEIF register. This is reference data, not investment advice.